New Endotoxin Detection System Removes Need for Horseshoe Crab Blood

A novel endotoxin detection system has been launched. The platform replaces the long‑standing practice of using horseshoe crab blood for testing. By eliminating the biological source, the system reduces reliance on a vulnerable marine species. It offers a synthetic or alternative method to identify bacterial endotoxins. The change could lower costs for pharmaceutical manufacturers. It also addresses animal‑welfare concerns raised by the traditional assay. Industry analysts expect broader adoption across biotech labs. The technology is expected to enter the market later this year.